Glimepiride 2 mg + Metformin 1000 mg tablets are an oral combination medicine used to help manage blood glucose levels in adults with type 2 diabetes mellitus. Glimepiride stimulates insulin release from the pancreas, while metformin reduces glucose production in the liver and improves the body's response to insulin.
Glimepiride 2 mg + Metformin 1000 mg is a combination antidiabetic medicine containing glimepiride, a sulfonylurea, and metformin, a biguanide. Both active ingredients help lower blood glucose but work in different ways.
This combination may be prescribed to improve blood glucose control in adults with type 2 diabetes when both medicines are considered appropriate. Its suitability depends on individual treatment needs, kidney function, medical history and other medicines being taken.
Glimepiride 2 mg + Metformin 1000 mg tablets may be prescribed to:
Help manage blood glucose levels in adults with type 2 diabetes mellitus.
Improve glycaemic control alongside an appropriate diet and regular physical activity.
Support diabetes management when treatment with both glimepiride and metformin is considered appropriate.
The appropriate treatment and dose should be determined by a healthcare professional based on blood glucose levels, kidney function, medical history and other medicines being used.
Glimepiride stimulates beta cells in the pancreas to release insulin, which helps glucose move from the bloodstream into the body's cells. This lowers blood glucose but can also cause hypoglycaemia, or low blood sugar.
Metformin primarily reduces glucose production in the liver and improves the body's sensitivity to insulin. It also reduces intestinal glucose absorption to a lesser extent.
Together, these medicines help regulate blood glucose through complementary mechanisms. The response varies between individuals and is assessed using blood glucose measurements and longer-term tests such as HbA1c.
Take Glimepiride + Metformin exactly as prescribed by your healthcare professional.
Timing: Glimepiride is generally taken with breakfast or the first main meal of the day. Follow the schedule prescribed for your specific combination product.
With food: Take the tablet with a meal as directed. This can help reduce digestive discomfort associated with metformin and support appropriate use of glimepiride.
Administration: Swallow the tablet according to the product instructions. Do not split or crush it unless the product information confirms this is appropriate.
Missed dose: Follow the patient information leaflet or ask your pharmacist what to do. Do not take a double dose to compensate for a missed dose.
Treatment changes: Do not stop treatment or change the dose without consulting your healthcare professional.
Follow your prescribed meal plan and blood glucose monitoring schedule, as irregular food intake can increase the risk of low blood sugar while taking glimepiride.
Tell your doctor or pharmacist about your medical history and all medicines, vitamins, supplements and herbal products you use before starting Glimepiride + Metformin.
Particular caution is required in people with:
Kidney impairment: Reduced kidney function can increase the risk of metformin accumulation and lactic acidosis. Kidney function should be assessed before and during treatment.
Liver disease: Liver impairment may increase the risks associated with metformin and requires medical evaluation.
A history of low blood sugar: Glimepiride can cause hypoglycaemia, particularly when meals are missed, food intake is inadequate or physical activity increases.
Heart failure, severe infection or dehydration: These conditions may affect kidney function or oxygen delivery to tissues and increase the risk of complications associated with metformin.
G6PD deficiency: Glimepiride may increase the risk of haemolytic anaemia in people with glucose-6-phosphate dehydrogenase deficiency.
Heavy alcohol consumption: Alcohol may increase the risk of hypoglycaemia and metformin-associated lactic acidosis.
Important interactions may occur with insulin and other blood glucose-lowering medicines, certain antifungal medicines such as miconazole, corticosteroids and medicines that affect kidney function or glucose regulation. Some imaging procedures involving iodinated contrast may also require a review of metformin treatment.
Seek urgent medical attention for symptoms that may indicate severe hypoglycaemia or lactic acidosis, including loss of consciousness, unusual weakness, muscle pain, abdominal discomfort or rapid or difficult breathing.
Check possible interactions and precautions with your doctor or pharmacist before starting or stopping any medicine.
Pregnancy: Diabetes treatment may need to change before or during pregnancy. Glimepiride crosses the placenta and may cause low blood sugar in newborns. If you are pregnant, planning a pregnancy or think you may be pregnant, consult your doctor promptly about the most appropriate treatment. Do not change your treatment without medical advice.
Breastfeeding: Metformin passes into breast milk in small amounts, while the extent to which glimepiride passes into human milk is uncertain. Glimepiride may pose a risk of low blood sugar in a breastfed infant. The suitability of this combination during breastfeeding depends on individual circumstances and local prescribing guidance, so consult your doctor before using it.
Like all medicines, Glimepiride + Metformin can cause side effects, although not everyone experiences them.
Common or recognised side effects may include:
Low blood sugar (hypoglycaemia), which may cause sweating, shaking, dizziness, hunger or confusion.
Headache.
Nausea or vomiting.
Diarrhoea.
Abdominal discomfort or indigestion.
Loss of appetite.
A metallic taste in the mouth.
Seek urgent medical attention for severe or persistent low blood sugar, loss of consciousness, serious allergic reactions, or symptoms that may indicate lactic acidosis, such as unusual weakness, muscle pain, abdominal pain or difficulty breathing.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Store Glimepiride + Metformin according to the instructions shown on the original product packaging.
Keep the tablets in their original packaging where appropriate.
Protect the medicine from heat, moisture and direct light as directed on the packaging.
Keep out of reach of children.
Do not use the medicine after its expiry date.
Ask a pharmacist how to dispose of unused or expired tablets.
It is an oral antidiabetic combination medicine prescribed to help manage blood glucose levels in adults with type 2 diabetes mellitus. It combines two active ingredients that lower blood glucose through different mechanisms.
Both ingredients begin acting after a dose, but the time needed to achieve the desired blood glucose control varies. Your healthcare professional can assess your response through blood glucose readings and longer-term tests such as HbA1c.
This combination is generally taken with meals as directed by the prescriber. Taking metformin with food can help reduce digestive discomfort, while taking glimepiride as directed with a meal helps manage the risk of low blood sugar.
The timing depends on the prescribed regimen and the specific product. Glimepiride is generally taken with breakfast or the first main meal of the day. Follow the instructions provided by your healthcare professional.
A generic product contains the active ingredients stated on its label at the specified strengths. Whether it can be substituted for a particular branded product depends on the approved formulation and applicable regulatory requirements. Check the product packaging or ask a pharmacist if you are unsure.
Do not stop taking the medicine solely because your blood glucose readings improve. Better readings may reflect the benefits of treatment, dietary changes and physical activity. Discuss any changes to your treatment with your healthcare professional.
Low blood sugar may cause sweating, shaking, dizziness, hunger or confusion. Follow your prescribed hypoglycaemia management plan and seek urgent medical assistance if symptoms are severe, persistent or accompanied by loss of consciousness. Do not give food or drink to someone who is unconscious.
